About Journal

About the Journal

Molecular Imaging is dedicated to publication of studies that combine recent advances in noninvasive imaging modalities with molecular and cellular biology in order to improve our understanding of normal and disease processes. This serves both the scientific and clinical communities by disseminating novel results and concepts relevant to the biological study of normal and disease processes in both basic and translational studies ranging from mice to humans.

Molecular Imaging is sponsored by the Society of Nuclear Medicine and is dedicated to the publication of early preclinical research, with special attention given to molecular- and cellular-level discoveries and non-nuclear techniques such as magnetic resonance imaging, magnetic resonance spectroscopy, ESR or EPR microscopy, optical imaging, intravital microscopy, diffuse optical tomography and other methods that elucidate molecular and cellular mechanisms and accelerate understanding of biology.

 

Scope

Molecular Imaging is a peer-reviewed journal highlighting the breadth of molecular imaging research from basic science to preclinical studies to human applications. The Journal covers all imaging modalities (e.g. nuclear, optical, magnetic resonance, ultrasound, photoacoustic, CT, etc.) as well as the development, application and validation of molecular imaging contrast agents and probes for cellular and molecular targets. Cellular and molecular targets include proteins, receptors, enzymes, genes and gene products that are present as a result of normal function or disease. Additionally, manuscripts may also cover the development of imaging hardware, quantitative modeling, in vitro and in vivo assays, animal model systems supporting targeted imaging approaches.

Manuscript Catagories

Molecular Imaging publishes Research Articles, Brief Reports, Reviews and Meeting Reports. Research Reports are full length original articles. Brief Reports are short, timely articles which may provide preliminary accounts of work of special interest or complete accounts of work of limited scope. While there are no specific length limitations for Brief Reports, authors are encouraged to keep them concise. Authors wishing to contribute a Review should contact the Editor. Reviews should focus on a recent development or issue in a single area, rather than attempt to exhaustively cover an entire topic. Meeting Reports should offer a synthesis of information presented at a scientific meeting that would be of interest to the general readership.

 

About the SNMMI

The Society of Nuclear Medicine and Molecular Imaging (SNMMI), headquartered in Reston, Va., is a nonprofit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging. SNMMI strives to be a leader in unifying, advancing and optimizing molecular imaging, with the ultimate goal of improving human health.

With 17,000 members worldwide, SNMMI represents nuclear and molecular imaging professionals, all of whom are committed to the advancement of the field. For more than 50 years, SNMMI members have developed—and continue to explore—innovations in medical imaging to allow for noninvasive diagnosis, management and treatment of diseases, benefiting countless patients. Members include physicians, technologists, physicists, pharmacists, scientists, laboratory professionals and more.

SNMMI provides leadership for advancing nuclear medicine and molecular imaging in the following key areas:

Research: SNMMI provides a forum in which researchers and physicians can readily communicate and collaborate to speed the process of evaluating scientific and clinical research and integrating it into clinical practice. SNMMI screens and hosts presentation of 1,500 papers on translational and clinical nuclear and molecular imaging studies at SNMMI’s annual meeting. Also, through its Center for Molecular Imaging Innovation and Translation and its Clinical Trials Network, SNMMI leads the way in groundbreaking research for nuclear and molecular imaging.

Education and training: SNMMI’s Annual Meeting and Mid-Winter Meeting provide the nuclear and molecular imaging community with robust education programs on the latest advances in the field. SNMMI also offers Maintenance of Certification courses as well as live and online learning opportunities through its Learning Center.

Professional standards and guidance for best practices: SNMMI works with its members to develop practice guidelines and accreditation standards.

Advocacy in the public policy and regulatory arenas: SNMMI is a leading player in providing guidance to legislators, regulators, activists and others involved in shaping the policies surrounding nuclear and molecular imaging. On behalf of its members, SNMMI advocates for improved policies and legislation for research, funding and reimbursement for molecular imaging.

Forums: SNMMI plays an important role in creating forums within which medical professionals from all medical disciplines collaborate on improving patient care.The society maintains strong relationships with international societies of nuclear medicine, universities, independent laboratories and suppliers of both equipment and radiopharmaceuticals.

The SNMMI national headquarters is located in Reston, Va., and 13 state/regional chapters are located throughout the United States and Canada. As a volunteer organization, SNMMI is governed by a policy-making board of directors, a house of delegates, committees and councils.

Molecular Imaging is now Open Access!

Molecular Imaging has transferred to an open access publication, effective January 1st, 2014

Molecular Imaging publishes studies that combine recent advances in noninvasive imaging modalities with molecular and cellular biology in order to improve understanding of normal and disease processes. This serves both the scientific and clinical communities by disseminating novel results and concepts in both basic and translational studies.

The journal is sponsored by the Society of Nuclear Medicine and Molecular Imaging and covers early preclinical research, with special attention to molecular- and cellular-level discoveries and non-nuclear techniques such as MRI, magnetic resonance spectroscopy, ESR or EPR microscopy, optical imaging, intravital microscopy, diffuse optical tomography and other methods that elucidate molecular and cellular mechanisms and accelerate understanding of biology.

Molecular Imaging is a peer-reviewed journal highlighting the breadth of molecular imaging research from basic science to preclinical studies to human applications. The Journal also addresses the development, application and validation of molecular imaging contrast agents and probes for cellular and molecular targets. Cellular and molecular targets include proteins, receptors, enzymes, genes and gene products that are present as a result of normal function or disease. Additionally, manuscripts may also cover the development of imaging hardware, quantitative modeling, in vitro and in vivo assays, animal model systems supporting targeted imaging approaches.

Submit your research to Molecular Imaging and take advantage of its efficient online submission process, a high quality peer-review service, and quick publication upon acceptance. There are no color charges and no limits on the number of figures. Submission fees are as follows:

Developed countries: $1900 per accepted article.
Developing countries: $950 per accepted article.

As an open access title, articles from Molecular Imaging will be freely accessible via full text repositories including PubMed and PubMed Central, which makes your research much more visible. This also complies with the open access policies of many funders including those of the Howard Hughes Medical Institute, NIH, and Wellcome Trust.

Molecular Imaging levies an article processing charge for each manuscript accepted after peer-review.

Submit your manuscript via : http://mc.manuscriptcentral.com/decker-mi

Yours sincerely,
Henry VanBrocklin, PhD
Editor-in-Chief, Molecular Imaging